To determine the accuracy of SCreening for Occult REnal Disease (SCORED) questionnaire for CKD risk among Asian Patients

Trial Identifier:	D1843R00353
Sponsor:	AstraZeneca
Start Date:	June 2023
Primary Completion Date:	May 2024
Study Completion Date:	May 2024
Condition:	Chronic Kidney Diseases

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Indonesia	Surabaya, Indonesia
Indonesia, Jawa barat	Bandung, Jawa barat, Indonesia, 40115
Vietnam	Ho Chi Minh City, Vietnam, 70000

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.